about
Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: clinical molecular and genetic studies on Alzheimer's diseaseDisease modifying therapies for Alzheimer's disease targeting Aβ oligomers: implications for therapeutic mechanisms[Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].Biomarkers of the dementia.Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease.Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease.Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.[Drug therapy for Alzheimer's disease].A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice.Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness.Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese.Temporal profile of neural stem cell proliferation in the subventricular zone after ischemia/hypoxia in the neonatal rat brain.Distribution of inducible nitric oxide synthase and cell proliferation in rat brain after transient middle cerebral artery occlusion.Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population.An unusual case of elderly-onset cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) with multiple cerebrovascular risk factors.A case of hereditary neuropathy with liability to pressure palsies due to push-up exercise.[Biomarker of dementia: clinical and preclinical diagnosis].[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy].Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse modelAging and are determinative factors of plasma A42 levelsSevere Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.Superoxide dismutase-encoding gene of the obligate anaerobe Porphyromonas gingivalis is regulated by the redox-sensing transcription activator OxyRA small trinucleotide expansion in the TBP gene gives rise to a sporadic case of SCA17 with abnormal putaminal findings on MRI[Expert/neurologist∼clinical][Conversion and reversion][Trend and outlook in clinical research for dementia][Functional Assessment Staging (FAST)]Disappearance of MRI imaging signals in a patient with neuronal intranuclear inclusion disease[DIAN/DIAN-J/DIAN-TU]Colocalization of Bunina bodies and TDP-43 inclusions in a case of sporadic amyotrophic lateral sclerosis with Lewy body-like hyaline inclusionsNeuropathology of PARK14 is identical to idiopathic Parkinson's diseaseNovel ELISAs to measure total and phosphorylated tau in cerebrospinal fluidCerebrospinal Fluid and Plasma Tau as a Biomarker for Brain TauopathyA soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseA New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome TechnologyAn autopsy case of primary lateral sclerosis with Alzheimer's diseaseCerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative DiseasesCogEvo, a cognitive function balancer, is a sensitive and easy psychiatric test battery for age-related cognitive declineMicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis
P50
Q26820870-EF889D81-5AEB-442B-B515-E446B81B4C16Q28680809-D3E15A86-519C-4C8B-8F86-50F94BB4C058Q34262790-351780A9-E4FB-4534-A4CB-80B2E8728812Q35030049-752050FC-7C72-4492-AE57-D79FFFD48ADAQ36037981-54B4784F-39E0-4EDE-A2D1-8B2DEE41268FQ40164228-5CF41D3C-DF4B-44B3-A6F8-31991062BF12Q42319753-637668DE-15A3-4F0A-9F64-236CB01CC589Q42904569-881D4629-3A70-4B38-AAFE-736F31B7F8FBQ42950165-7435E5E0-CC23-48F7-873E-9C24DE599115Q46061994-661A6AD5-736C-45CF-B6C0-CF095E9E48BAQ47743946-F27F7B55-0257-4556-B733-DAA22929C7C2Q47799916-52490F1D-04C7-4C79-A663-FD7E35F1E65AQ48507007-A1514429-821D-4285-AB7C-94E2FAA06F63Q48539105-A0A26915-68FB-4C11-8CCC-239CFE542CD5Q50473031-8E679F7A-AA9A-44A5-BCFE-A0C80DA22FCFQ51036999-54E10F11-3318-4DD3-9B85-BF9E26FD820BQ52856801-510EA34C-AF16-440D-A4BC-70C1F27F33B9Q53437705-1E026887-C042-498C-B0D2-C04C44EA5E6AQ53464110-6043300C-B3D8-43EC-938B-3F8D73EF0671Q57419037-D6E283F6-0471-447D-8DB8-EF78A44612EDQ57822409-30DC4243-85B2-425F-B1B0-99670AB9779AQ64930865-A8FF4281-A61D-46EC-BC8E-51474E3716AFQ82891253-7C848C1A-EE5A-40EC-8BED-AF727EE6A55DQ82930882-B14B3FBE-E56C-4771-82B9-E028E34520ECQ83324809-099C65BE-C1DF-4E1C-B4EA-D7B9756F4917Q84512037-92D7DB4E-B43F-4FA2-881D-BCD6A5F1A116Q84566114-A84AF638-B2C0-4DAB-9646-631DC7288072Q84566271-65DDC209-D34F-4377-973C-C011A5D8E4A3Q88297950-0F4D578E-933B-4564-B5E4-637489FF3CA5Q88594469-656FC0A0-899A-4F8B-B530-B392516581D4Q89230343-E9B4CA79-A10A-4E2D-A93E-A29E1A7D1A15Q89300922-5D035B10-5B1C-4D30-AD94-102C61C324A1Q89656294-1B2EEF12-6724-4009-A287-07849B507BB7Q89871517-AEB46589-9BC5-491F-9287-E5B2AC38999BQ90246734-4ABE6522-9D4D-4E8B-BDC2-B37F5EF902B8Q91467897-ADA258BB-C56C-4722-B223-9AFC69E5095BQ91513518-0A776FDA-BEF3-4DFA-826B-B017EA5F4615Q91984502-406752B5-17E0-4752-BF80-D5F227DA6DB6Q92083656-CBFAFDF9-6A3D-498E-8472-2A146F3AD72FQ92586264-0FA3C32C-4366-41FF-9F0A-CC0E07B72B7B
P50
description
researcher (ORCID 0000-0003-1027-1712)
@en
wetenschapper
@nl
name
Mikio Shoji
@en
Mikio Shoji
@nl
type
label
Mikio Shoji
@en
Mikio Shoji
@nl
prefLabel
Mikio Shoji
@en
Mikio Shoji
@nl
P31
P496
0000-0003-1027-1712